Steven A. Kaplan

How to manage your reputation, recruit patients onlineIn today’s digital world, having an active professional presence online has become a must.
Opioid abuse: How it is impacting men’s health"There are direct endocrine consequences of opioid use, including hypogonadism, that adversely impact men’s health," write Michael S. Leapman, MD, and Steven A. Kaplan, MD.
Tech advances catalyze paradigm shifts in patient careJames M. Hotaling, MD, MS, and Steven A. Kaplan, MD, introduce their new Urology Times section "Tech Talk with Jim and Steve."
Data cast light on ED/5-ARI connection
HPV infection in men: Prevalence and vaccination coverage
HPV infection in men: Prevalence and vaccination coverage
How to improve health information online for our patients
How to improve health information online for our patients"Those patients (and their caregivers) who take ownership of more aspects of their health care experience, including relevant and personalized information, will have better outcomes," writes Steven A. Kaplan, MD.
LUTS’ burden may extend to cardiac events"LUTS is an important health care burden, and health care professionals should be screening for its presence in men at risk," writes Steven A. Kaplan, MD.
AUA 2016: Experts offer guidance on the meetingTo guide you through the 2016 AUA annual meeting and help maximize your time, Urology Times’ editorial board has reviewed the program to identify the key trends and noteworthy research at this year’s meeting.
'T' clinics create concerns about care, competitionOne only needs to do a Google search for “testosterone clinic” to realize there’s an explosion of for-profit businesses branded as men’s health establishments, offering what sounds like the fountain of youth to men with “low T” and sexual dysfunction. Unless one of these practices is affiliated with an academic medical center or urology group, there’s a good chance urologists are not part of the picture.
ED, diabetes, and CV risk: Update on treatment, risk reductionIn this article, we review the etiology and pathophysiology of ED in this challenging patient population and provide an approach to treatment and risk reduction via lifestyle modification and pharmacologic intervention.